Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)

146.05
Delayed Data
As of Mar 29
 +0.14 / +0.10%
Today’s Change
95.80
Today|||52-Week Range
160.00
+33.95%
Year-to-Date
Jazz Sleep Disorder Drug Positive in Phase III Studies
Mar 21 / Zacks.com - Paid Partner Content
Jazz Initiates Phase III Study for Narcolepsy Candidate
Mar 16 / Zacks.com - Paid Partner Content